Comparative activities of LY 333328, a new glycopeptide, against penicillin-susceptible and -resistant pneumococci

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 11, 1996, Pages 2661-2663

  Fasola, Elizabeth ^a   Spangler, Sheila K ^b   Ednie, Lois M ^b   Jacobs, Michael R ^a   Bajaksouzian, Saralee ^a   Appelbaum, Peter C ^b  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFOTAXIME; CEFTRIAXONE; GLYCOPEPTIDE; IMIPENEM; ORITAVANCIN; PENICILLIN G; RIFAMPICIN; TEICOPLANIN; UNCLASSIFIED DRUG; VANCOMYCIN;

ANTIBACTERIAL ACTIVITY; BACTERIAL MENINGITIS; CONFERENCE PAPER; DRUG MIXTURE; MINIMUM INHIBITORY CONCENTRATION; PENICILLIN RESISTANCE; PRIORITY JOURNAL; STRAIN DIFFERENCE; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE;

EID: 0029861540     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.11.2661     Document Type: Conference Paper

References (18)

1. Appelbaum, P. C. 1992. Antimicrobial resistance in Streptococcus pneumoniae: an overview. Clin. Infect. Dis. 15:77-83.
2. Block, S., J. Hedrick, P. Wright, R. Finger, R. Leggiadro, M. Appleton, S. Kahn, and R. Hutcheson. 1994. Drug-resistant Streptococcus pneumonia - Kentucky and Tennessee, 1993. Morbid. Mortal. Weekly Rep. 43:23-25, 31.
3. Boylan, C. J., T. I. Nicas, D. A. Preston, D. L. Zeckner, B. J. Boyll, P. A. Raab, D. L. Mullen, N. J. Snyder, L. L. Zornes, R. E. Stratford, M. J. Zweifel, S. C. Wilkie, M. J. Rodriguez, R. C. Thompson, and R. D. G. Cooper. 1995. Efficacy of semisynthetic glycopeptides active against vancomycin-resistant enterococci in a mouse infection model, abstr. F255, p. 157. In Abstracts of the 35th Interscicnce Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
4. Breiman, R. F., J. C. Butler, F. C. Tenover, J. A. Elliott, and R. R. Facklam. 1994. Emergence of drug-resistant pneumococcal infections in the United States. JAMA 271:1831-1835.
5. Friedland, I. R., and G. H. McCracken, Jr. 1994. Management of infections caused by antibiotic-resistant Streptococcus pneumoniae. N. Engl. J. Med. 331:377-382.
6. Goldstein, F. W., P. Geslin, J. F. Acar, and the French Study Group. 1994. Comparative activity of teicoplanin and vancomycin against 400 penicillin susceptible and resistant Streptococcus pneumoniae. Eur. J. Clin. Microbiol. Infect. Dis. 13:33-34.
7. Jacobs, M. R. 1992. Treatment and diagnosis of infections caused by drug-resistant Streptococcus pneumoniae. Clin. Infect. Dis. 15:119-127.
8. Jacobs, R. F., S. L. Kaplan, G. E. Schutze, A. S. Dajani, R. J. Leggiadro, C.-S. Rim, and S. K. Puri. 1996. Relationship of MICs to efficacy of cefotaxime in treatment of Streptococcus pneumoniae infections. Antimicrob. Agents Chemother. 40:895-898.
9. Klugman, K. P., R. Dagan, and the Meropenem Meningitis Study Group. 1995. Randomized comparison of meropenem with cefotaxime for treatment of bacterial meningitis. Antimicrob. Agents Chemother. 39:1140-1146.
10. Lin, Y., R. E. Stratford, L. L. Zornes, W. L. Confer, V. Vasudevan, T. W. Jones, T. I. Nicas, D. A. Preston, C. J. Boylan, D. L. Zeckner, B. J. Boyll, P. A. Raab, N. J. Snyder, M. J. Zweifel, S. C. Wilkie, M. J. Rodriguez, R. C. Thompson, and R. D. G. Cooper. 1995. Non-clinical pharmacokinetics of LY333328, a semisynthetic glycopeptide antibiotic active against vancomycin-resistant enterococci, abstr. F254, p. 157. In Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
11. National Committee for Clinical Laboratory Standards. 1995. Performance standards for antimicrobial susceptibility testing. M100-S5. National Committee for Clinical Laboratory Standards, Villanova, Pa.
12. Nicas, T. I., J. E. Flokowitsch, D. A. Preston, D. L. Mullen, J. Grissom-Arnold, N. J. Snyder, M. J. Zweifel, S. C. Wilkie, M. J. Rodriguez, R. C. Thompson, and R. D. G. Cooper. 1995. Semisynthetic glycopeptides active against vancomycin-resistant enterococci: activity against staphylococci and streptococci in vitro and in vivo, abstr. F248, p. 156. In Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
13. Nicas, T. I., D. L. Mullen, J. Grissom-Arnold, N. J. Snyder, M. J. Zweifel, S. C. Wilkie, M. J. Rodriguez, R. C. Thompson, and R. D. G. Cooper. 1995. Semisynthetic glycopeptides active against vancomycin-resistant enterococci: in vitro activity against enterococci, abstr. F249, p. 156. In Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
14. Pankuch, G. A., M. R. Jacobs, and P. C. Appelbaum. 1994. Study of comparative antipneumococcal activities of penicillin G, RP 59500, erythromycin, sparfloxacin, ciprofloxacin, and vancomycin by using time-kill methodology. Antimicrob. Agents Chemother. 38:2065-2072.
15. París, M. M., O. Ramilo, and G. H. McCracken, Jr. 1995. Management of meningitis caused by penicillin-resistant Streptococcus pneumoniae. Antimicrob. Agents Chemother. 39:2171-2175.
16. Spangler, S. K., M. R. Jacobs, and P. C. Appelbaum. 1992. Susceptibilities of penicillin-susceptible and -resistant strains of Streptococcus pneumoniae to RP 59500, vancomycin, erythromycin, PD 131628, sparfloxacin, temafloxacin. Win 57273, ofloxacin, and ciprofloxacin. Antimicrob. Agents Chemother. 36:856-859.
17. Spangler, S. K., M. R. Jacobs, and P. C. Appelbaum. 1996. Activities of RPR 106972 (a new oral streptogramin), cefditoren (a new oral cephalosporin). two new oxazolidinones (U-100592 and U-100766), and other oral and parenteral agents against 203 penicillin-susceptible and -resistant pneumococci. Antimicrob. Agents Chemother. 40:481-484.
18. Viladrich, P. F., F. Gudiol, J. Linãres, R. Pallarés, I. Sabaté, G. Rufi, and J. Ariza. 1991. Evaluation of vancomycin for therapy of adult pneumococcal meningitis. Antimicrob. Agents Chemother. 35:2467-2472.